C
5.71
0.06 (1.06%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | Coya Therapeutics, Inc. | 混合的 | 混合的 |
AIStockmoo 评分
1.3
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | 1.0 |
| 技术平均移动指标 | 3.5 |
| 技术振荡指标 | -2.5 |
| 平均 | 1.25 |
|
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 7.02% |
| 机构持股比例 | 28.05% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Dme Capital Management, Lp | 31 Mar 2025 | 1,646,440 |
| Aigh Capital Management Llc | 31 Mar 2025 | 1,183,780 |
| Cm Management, Llc | 31 Mar 2025 | 200,000 |
| Ghp Investment Advisors, Inc. | 31 Mar 2025 | 26,171 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 18.00 (D. Boral Capital, 215.24%) | 购买 |
| 中 | 16.00 (180.21%) | |
| 低 | 14.00 (Chardan Capital, 145.18%) | 购买 |
| 平均值 | 16.00 (180.21%) | |
| 总计 | 2 购买 | |
| 平均价格@调整类型 | 6.15 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Chardan Capital | 13 May 2025 | 14.00 (145.18%) | 购买 | 5.76 |
| 28 Apr 2025 | 14.00 (145.18%) | 购买 | 6.17 | |
| D. Boral Capital | 24 Apr 2025 | 18.00 (215.24%) | 购买 | 6.53 |
| 22 Apr 2025 | 18.00 (215.24%) | 购买 | 6.64 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合